Neurology, Neuroimmunology and Neuroinflammation
ISSN: 2332-7812
Publisher: Lippincott, Williams & Wilkins
Publications (23)
Single-Cell Multi-Omics Map of Cell Type-Specific Mechanistic Drivers of Multiple Sclerosis Lesions (2024)
Elkjaer ML, Hartebrodt A, Oubounyt M, Weber A, Vitved L, Reynolds R, Thomassen M, et al.
Journal article
Antibodies Against Glutamic Acid Decarboxylase 65 Are Locally Produced in the CSF and Arise During Affinity Maturation (2023)
Biljecki M, Eisenhut K, Beltrán E, Winklmeier S, Mader S, Thaller A, Eichhorn P, et al.
Journal article
Treatment With Erythropoietin for Patients With Optic Neuritis: Long-term Follow-up. (2023)
Küchlin S, Ihorst G, Grotejohann B, Beisse F, Heinrich SP, Albrecht P, Ungewiss J, et al.
Journal article
Seizure Semiology in Antibody-Associated Autoimmune Encephalitis (2022)
Kaaden T, Madlener M, Angstwurm K, Bien CG, Bogarin Y, Doppler K, Finke A, et al.
Journal article
Dynamics of Retinal Vessel Loss After Acute Optic Neuritis in Patients With Relapsing Multiple Sclerosis (2022)
Aly L, Noll C, Wicklein R, Wolf E, Romahn EF, Wauschkuhn J, Hosari S, et al.
Journal article
The Aryl Hydrocarbon Receptor-Dependent TGF-α/VEGF-B Ratio Correlates With Disease Subtype and Prognosis in Multiple Sclerosis (2021)
Cirac A, Tsaktanis T, Beyer T, Linnerbauer M, Andlauer T, Grummel V, Nirschl L, et al.
Journal article
B-Cell Activity Predicts Response to Glatiramer Acetate and Interferon in Relapsing-Remitting Multiple Sclerosis (2021)
Tacke S, Braune S, Rovituso DM, Ziemssen T, Lehmann P, Dikow H, Bergmann A, Kürten S
Journal article
Aryl Hydrocarbon Receptor Activation in Astrocytes by Laquinimod Ameliorates Autoimmune Inflammation in the CNS (2021)
Rothhammer V, Kenison JE, Li Z, Tjon E, Takenaka MC, Chao CC, Alves de Lima K, et al.
Journal article
Aryl Hydrocarbon Receptor Plasma Agonist Activity Correlates With Disease Activity in Progressive MS (2021)
Tsaktanis T, Beyer T, Nirschl L, Linnerbauer M, Grummel V, Bussas M, Tjon E, et al.
Journal article
CSF Findings in Acute NMDAR and LGI1 Antibody-Associated Autoimmune Encephalitis. (2021)
Duerr M, Nissen G, Suehs KW, Schwenkenbecher P, Geis C, Ringelstein M, Hartung HP, et al.
Journal article